WO2003047546A3 - Mittel zur behandlung von übergewicht in kombination mit weiteren indikationen - Google Patents

Mittel zur behandlung von übergewicht in kombination mit weiteren indikationen Download PDF

Info

Publication number
WO2003047546A3
WO2003047546A3 PCT/EP2002/013634 EP0213634W WO03047546A3 WO 2003047546 A3 WO2003047546 A3 WO 2003047546A3 EP 0213634 W EP0213634 W EP 0213634W WO 03047546 A3 WO03047546 A3 WO 03047546A3
Authority
WO
WIPO (PCT)
Prior art keywords
agent
association
excess weight
indications
treating excess
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/013634
Other languages
English (en)
French (fr)
Other versions
WO2003047546A2 (de
Inventor
Guenther Beisel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP02804214A priority Critical patent/EP1450763B1/de
Priority to AT02804214T priority patent/ATE498389T1/de
Priority to AU2002365632A priority patent/AU2002365632A1/en
Priority to DE50214914T priority patent/DE50214914D1/de
Publication of WO2003047546A2 publication Critical patent/WO2003047546A2/de
Publication of WO2003047546A3 publication Critical patent/WO2003047546A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Road Signs Or Road Markings (AREA)
  • Water Treatment By Sorption (AREA)
  • Fertilizers (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Die vorliegende Erfindung betrifft ein Mittel zur Behandlung von Übergewicht in Kombination mit mindestens einer weiteren Indikation enthaltend ein in gastrointestinalen Flüssigkeiten und/oder Körperflüssigkeiten unlösliches oder schwer lösliches, volumenvergrößerndes Material und wenigstens eine wirkstoffhaltige Formulierung, durch eine gemeinsame Umhüllungslage verbunden sind, oder die derart löslich miteinander verbunden sind, dass unter den Milieubedingungen im Magen das Material und die Formulierung voneinander getrennt werden.
PCT/EP2002/013634 2001-12-06 2002-12-03 Mittel zur behandlung von übergewicht in kombination mit weiteren indikationen Ceased WO2003047546A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP02804214A EP1450763B1 (de) 2001-12-06 2002-12-03 Mittel zur behandlung von übergewicht in kombination mit weiteren indikationen
AT02804214T ATE498389T1 (de) 2001-12-06 2002-12-03 Mittel zur behandlung von übergewicht in kombination mit weiteren indikationen
AU2002365632A AU2002365632A1 (en) 2001-12-06 2002-12-03 Agent for treating excess weight in association with other indications
DE50214914T DE50214914D1 (de) 2001-12-06 2002-12-03 Mittel zur behandlung von übergewicht in kombination mit weiteren indikationen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10164680.1 2001-12-06
DE10164680 2001-12-06

Publications (2)

Publication Number Publication Date
WO2003047546A2 WO2003047546A2 (de) 2003-06-12
WO2003047546A3 true WO2003047546A3 (de) 2004-03-18

Family

ID=7711270

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/013634 Ceased WO2003047546A2 (de) 2001-12-06 2002-12-03 Mittel zur behandlung von übergewicht in kombination mit weiteren indikationen

Country Status (5)

Country Link
EP (1) EP1450763B1 (de)
AT (1) ATE498389T1 (de)
AU (1) AU2002365632A1 (de)
DE (1) DE50214914D1 (de)
WO (1) WO2003047546A2 (de)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4869908A (en) * 1987-01-09 1989-09-26 K.V. Pharmaceutical Co. Fibre formulations
US5010061A (en) * 1986-04-18 1991-04-23 Ulrich Speck Guar flour
EP1029892A1 (de) * 1999-02-10 2000-08-23 Dr. Suwelack Skin & Health Care AG Polysaccharid-, insbesondere paramylonenthaltendes gefriergetrocknetes Mittel, seine Herstellung und Verwendung
WO2001017377A1 (de) * 1999-09-06 2001-03-15 Beisel Guenther Vernetztes mittel zur erzeugung eines langanhaltenden sättigungseffekts und verfahren zu dessen herstellung
DE20119843U1 (de) * 2001-12-06 2002-04-18 Beisel, Günther, 40789 Monheim Mittel zur Behandlung von Übergewicht und weiteren Symptomen

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010061A (en) * 1986-04-18 1991-04-23 Ulrich Speck Guar flour
US4869908A (en) * 1987-01-09 1989-09-26 K.V. Pharmaceutical Co. Fibre formulations
EP1029892A1 (de) * 1999-02-10 2000-08-23 Dr. Suwelack Skin & Health Care AG Polysaccharid-, insbesondere paramylonenthaltendes gefriergetrocknetes Mittel, seine Herstellung und Verwendung
WO2001017377A1 (de) * 1999-09-06 2001-03-15 Beisel Guenther Vernetztes mittel zur erzeugung eines langanhaltenden sättigungseffekts und verfahren zu dessen herstellung
DE20119843U1 (de) * 2001-12-06 2002-04-18 Beisel, Günther, 40789 Monheim Mittel zur Behandlung von Übergewicht und weiteren Symptomen

Also Published As

Publication number Publication date
EP1450763B1 (de) 2011-02-16
DE50214914D1 (de) 2011-03-31
ATE498389T1 (de) 2011-03-15
WO2003047546A2 (de) 2003-06-12
AU2002365632A8 (en) 2003-06-17
AU2002365632A1 (en) 2003-06-17
EP1450763A2 (de) 2004-09-01

Similar Documents

Publication Publication Date Title
EP1293557A3 (de) Wasserlösliche Packung enthaltend eine flüssige Zusammensetzung mit einer visuell unterscheidbaren Kapsel oder Emulsion oder Dispersionsschicht
WO1996025922A3 (en) Banded prolonged release active agent dosage form
WO2004037316A3 (en) Nanoparticle delivery system
WO2002072073A3 (en) Pharmaceutical formulation comprising atorvastatin calcium
BR0211947A (pt) Embalagens solúveis em água
TNSN01123A1 (fr) Formes posologiques nouvelles a liberation controlee
WO2005007115A3 (en) Pharmaceutical composition for inhibiting acid secretion
EP1842567A3 (de) Intraluminale Vorrichtung mit einer therapeutisches Mittel enthaltenden Beschichtung
SG80553A1 (en) Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
EP1127804A3 (de) Absorbierende Verpackung
WO2003045523A3 (en) Therapeutic coating for an intravascular implant
AU5680100A (en) Controlled release and taste masking oral pharmaceutical compositions
WO2007018943A3 (en) Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
WO2008067164A3 (en) Solid pharmaceutical dosage formulations
WO2004087011A3 (en) Therapeutic agent delivery device with controlled therapeutic agent release rates
HK1051487A1 (zh) 含有阿片样激动剂和拮抗剂的控释组合物
AU2003212306A1 (en) Pharmaceutical formulation for the active ingredient budesonide
WO2003028696A3 (en) Compositions for delivery of drug combinations
CA2299420A1 (en) Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
PT1328268E (pt) Combinacao de catequina e quercetina para utilizacao farmaceutica ou dietetica
WO2002080887A3 (en) Timed pulse release composition
CA2497171A1 (en) Water stabilized medicinal aerosol formulation
WO2006021160A8 (fr) Système de relargage de médicament auto-émulsifiant à base de butylbenzènephtaléine, méthode de préparation et applications d’un tel système
PT1272167E (pt) Formulação de dosagem de matriz polimérica hidrófila/lipófila contendo ropinirole
WO2006055237A3 (en) Therapeutic driving layer for a medical device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002804214

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002804214

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP